SCHEMBL8118484

SCHEMBL8118484

Cn1c(CNC(=O)C(C)(C)C)nc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 1.00
ALDH1A1 P00352 4/20 0.76
L3MBTL1 Q9Y468 3/20 0.70
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
RECQL P46063 1/20 0.57
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
LMNA P02545 3/20 0.57
KDM4E B2RXH2 2/20 0.56
HDAC6 Q9UBN7 1/20 0.55
GAA P10253 1/20 0.54
TSHR P16473 1/20 0.53
PKM P14618 1/20 0.52
TP53 P04637 1/20 0.52
ALOX15 P16050 1/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16133680 0.86 ALDH1A1 (1.00) MAPTALDH1A1L3MBTL1RECQLSMN1; SMN2
SCHEMBL2937868 0.84 MAPT (0.72) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL13649464 0.84 MAPT (0.72) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL30466612 0.83 MAPT (0.70) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL28366489 0.83 MAPT (0.70) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL8401361 0.82 MAPT (0.69) MAPTMEN1KMT2ARECQLNPC1
SCHEMBL12862985 0.82 RECQL (0.78) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6935651 0.80 MAPT (0.66) MAPTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL31124209 0.80 MAPT (0.66) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL13958841 0.78 NPC1 (0.65) MAPTALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 MAPT 2802/4885ALDH1A1 854/4885L3MBTL1 1644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.